Equities analysts expect UnitedHealth Group Inc (NYSE:UNH) to post $54.85 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Six analysts have made estimates for UnitedHealth Group’s earnings, with the highest sales estimate coming in at $55.38 billion and the lowest estimate coming in at $54.15 billion. UnitedHealth Group posted sales of $48.72 billion in the same quarter last year, which suggests a positive year-over-year growth rate of 12.6%. The business is expected to report its next quarterly earnings results on Tuesday, April 17th.
According to Zacks, analysts expect that UnitedHealth Group will report full-year sales of $54.85 billion for the current year, with estimates ranging from $223.50 billion to $225.58 billion. For the next fiscal year, analysts forecast that the company will report sales of $242.64 billion per share, with estimates ranging from $240.11 billion to $245.44 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that that provide coverage for UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The firm had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. During the same quarter in the prior year, the firm earned $2.11 EPS. UnitedHealth Group’s quarterly revenue was up 9.5% on a year-over-year basis.
UnitedHealth Group (NYSE:UNH) traded up $3.90 during midday trading on Wednesday, reaching $234.06. 3,310,000 shares of the company’s stock traded hands, compared to its average volume of 4,430,000. UnitedHealth Group has a 1 year low of $161.74 and a 1 year high of $250.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58. The company has a market cap of $226,490.00, a PE ratio of 24.64, a price-to-earnings-growth ratio of 1.34 and a beta of 0.70.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.28%. The ex-dividend date is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 31.58%.
In related news, Director Michele J. Hooper sold 10,000 shares of the stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $237.76, for a total transaction of $2,377,600.00. Following the completion of the sale, the director now directly owns 37,284 shares of the company’s stock, valued at $8,864,643.84. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Over the last three months, insiders have sold 53,396 shares of company stock valued at $12,262,067. Company insiders own 0.89% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in UNH. Capital International Investors lifted its position in shares of UnitedHealth Group by 399.3% in the 3rd quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after acquiring an additional 3,304,902 shares in the last quarter. Jennison Associates LLC lifted its position in shares of UnitedHealth Group by 146.0% in the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after acquiring an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC lifted its position in shares of UnitedHealth Group by 1,820.1% in the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after acquiring an additional 2,264,242 shares in the last quarter. Egerton Capital UK LLP purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $368,905,000. Finally, Vanguard Group Inc. lifted its position in shares of UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after acquiring an additional 1,588,516 shares in the last quarter. 85.65% of the stock is owned by institutional investors and hedge funds.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.